Clinical Solutions Innovating Medical Research, or CSI Medical Research, is a contract research organization (CRO) providing innovative, cost-effective, and efficient clinical solutions in Singapore since 2017. We believe in implementing innovative automation by focusing on patient safety and care in clinical trials.

​​

CSI Medical Research has extensive industry experience and knowledge of local practices, regional ethics, regulatory requirements, and site operations, making us your preferred strategic partner. We hope to aid more companies to confidently enter the Southeast Asian market with us for innovative and cost-effective solutions.

​

Since our incorporation in Singapore in 2017, CSI Medical Research has gone on to set up its entities in Malaysia (2020) and Australia (2022). We aim to be recognized as SEA’s most trustworthy CRO by 2025, with the focus on delivering our various services in clinical trials within Asia–Pacific countries.

​

On 12 January 2024, CSI Medical Research was acquired by ClinChoice, a leading global CRO. Through this acquisition and merger, ClinChoice further broadens its global footprint and full-service capabilities in more than 30 countries throughout Asia, Europe, and North America.  ​

​

For more information, email us at smx-sg-bd@clinchoice.com